STOCK TITAN
  1. Home
  2. Sec-filings
  3. PROK
  4. [EFFECT] ProKidney Corp. SEC Filing

[EFFECT] ProKidney Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 7, 2025
Accession Number: 0001140361-25-024903
Submission Type: POS AM
CIK: 0001850270
Company Name: PROKIDNEY CORP.
File Number: 333-275701

Source: View Original Filing on SEC EDGAR

Stock PROK logo
ProKidney

NASDAQ:PROK

PROK Rankings

#3531 Ranked by Market Cap
N/A Ranked by Dividends

PROK Latest News

Oct 20, 2025
ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025
Aug 27, 2025
ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference
Aug 12, 2025
ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
Jul 15, 2025
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
Jul 9, 2025
ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

PROK Latest SEC Filings

Oct 21, 2025
[POS AM] PROKIDNEY CORP. SEC Filing
Oct 17, 2025
[8-K] PROKIDNEY CORP. Reports Material Event
Aug 12, 2025
[8-K] ProKidney Corp. Reports Material Event
Aug 12, 2025
[10-Q] ProKidney Corp. Quarterly Earnings Report
Aug 7, 2025
[SCHEDULE 13G/A] ProKidney Corp. SEC Filing

PROK Stock Data

433.77M
99.06M
28.84%
30.46%
6.21%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
WINSTON-SALEM